⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5580621 | 0.72 | — | — | |
| SCHEMBL1040949 | 0.72 | — | — | |
| SCHEMBL42915 | 0.72 | — | — | |
| SCHEMBL667574 | 0.72 | — | — | |
| SCHEMBL61261 | 0.69 | — | — | |
| SCHEMBL3475221 | 0.69 | — | — | |
| SCHEMBL181898 | 0.69 | — | — | |
| SCHEMBL7505413 | 0.69 | — | — | |
| SCHEMBL21811944 | 0.69 | — | — | |
| SCHEMBL6963543 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0002680-A2 | 4-Spectinomycylamin and its physiologically acceptable salts, method of preparation and pharmaceutical products containing these substances | Dr. Karl Thomae GmbH (DE) | 1979-07-11 | — | — | EP | claimed |
| CN-118139839-A | Process for producing fluorinated polyether | 株式会社力森诺科 | 2024-06-04 | — | — | CN | disclosed |
| CN-118055920-A | Process for producing fluorinated polyether | 株式会社力森诺科 | 2024-05-17 | — | — | CN | disclosed |
| US-20200181187-A1 | PROCESS FOR THE PREPARATION OF (S,S)-SECOISOLARICIRESINOL DIGLUCOSIDE AND (R,R)-SECOISOLARICIRESINOL DIGLUCOSIDE | LIGNAMED LLC (US) | 2020-06-11 | — | — | US | disclosed |
| EP-3638220-A1 | PROCESS FOR THE PREPARATION OF (S,S | LignaMed, LLC (US) | 2020-04-22 | — | — | EP | disclosed |
| CN-110831583-A | Method for preparing (S, S) -secoisolariciresinol diglucoside and (R, R) -secoisolariciresinol diglucoside | 利格那梅德有限责任公司 | 2020-02-21 | — | — | CN | disclosed |
| WO-2018231691-A1 | PROCESS FOR THE PREPARATION OF (S,S)-SECOISOLARICIRESINOL DIGLUCOSIDE AND (R,R)-SECOISOLARICIRESINOL DIGLUCOSIDE | LIGNAMED, LLC (US) | 2018-12-20 | — | — | WO | disclosed |
| US-20170190695-A1 | PARASITE- AND HYGIENIC PEST-CONTROLLING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-07-06 | — | — | US | disclosed |
| US-9637480-B2 | Parasite- and hygienic pest-controlling agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-05-02 | — | — | US | disclosed |
| EP-2364298-B1 | QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMA CO LTD (JP) | 2016-08-03 | — | — | EP | disclosed |
| WO-1997030059-A1 | SUBSTITUTED 2-PHENYLPYRIDINES | BASF AKTIENGESELLSCHAFT (DE) | 1997-08-21 | — | — | WO | disclosed |
| WO-1997001543-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-16 | — | — | WO | disclosed |
| CN-1101908-A | Angiotensin II antagonists | LILLY CO ELI (US) | 1995-04-26 | — | — | CN | disclosed |
| US-4487781-A | HEAT RESISTANCE; PHOTOSTABILITY | SANKYO COMPANY LIMITED (JP) | 1984-12-11 | — | — | US | disclosed |
| EP-0005248-B1 | TETRAPEPTIDEHYDRAZIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | Takeda Chemical Industries, Ltd. (JP) | 1982-03-24 | — | — | EP | disclosed |
| US-4277394-A | ANALGESICS, ANTIDIARRHEA, TREATMENT OF MENTAL DISEASE | TAKEDA CHEMICAL INDUSTRIES, LTD (JP) | 1981-07-07 | — | — | US | disclosed |
| US-4259350-A | PROTECTING DEGRADABLE ORGANIC MATERIAL FROM FUNGAL OR INSECT ATTACK | SANKYO COMPANY LIMITED (JP) | 1981-03-31 | — | — | US | disclosed |
| EP-0002680-B1 | 4-SPECTINOMYCYLAMIN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS, METHOD OF PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE SUBSTANCES | Dr. Karl Thomae GmbH (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-4173647-A | ANTIMICROBIAL | BOEHRINGER INGELHEIM GMBH (DE) | 1979-11-06 | — | — | US | disclosed |
| EP-0002680-A2 | 4-Spectinomycylamin and its physiologically acceptable salts, method of preparation and pharmaceutical products containing these substances | Dr. Karl Thomae GmbH (DE) | 1979-07-11 | — | — | EP | disclosed |